DuBell WH et al. |
K(+) currents responsible for repolarization in mouse ventricle and their modulation by FK-506 and rapamycin. |
2000 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:10710358
|
Giordano A et al. |
Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells. |
2012 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:22058159
|
Fauconnier J et al. |
Frequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15471978
|
Balasubramaniam R et al. |
Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15923307
|
Liu Y et al. |
Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6. |
2012 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:22408025
|
Sasamori K et al. |
Cyclic ADP-ribose, a putative Ca2+-mobilizing second messenger, operates in submucosal gland acinar cells. |
2004 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:14990397
|
Lum H et al. |
Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction. |
2001 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:11504680
|
Yaghi A and Sims SM |
Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:16055480
|
Bouvier N et al. |
Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:18987109
|
Ren H et al. |
Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane. |
2016 |
Am. J. Physiol. Renal Physiol. |
pmid:27488997
|
Thai TL et al. |
ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo. |
2007 |
Am. J. Physiol. Renal Physiol. |
pmid:17652368
|
Peherstorfer E et al. |
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. |
2002 |
Am. J. Physiol. Renal Physiol. |
pmid:12060601
|
Axelsson J et al. |
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. |
2013 |
Am. J. Physiol. Renal Physiol. |
pmid:23657856
|
Mohebbi N et al. |
The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. |
2009 |
Am. J. Physiol. Renal Physiol. |
pmid:19439519
|
Cho SG et al. |
Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. |
2010 |
Am. J. Physiol. Renal Physiol. |
pmid:20410216
|
De Miguel C et al. |
Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. |
2011 |
Am. J. Physiol. Renal Physiol. |
pmid:21159736
|
Rojas-Vega L et al. |
Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort. |
2015 |
Am. J. Physiol. Renal Physiol. |
pmid:26336164
|
Edinger RS et al. |
Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells. |
2002 |
Am. J. Physiol. Renal Physiol. |
pmid:12110508
|
Ilori TO et al. |
Acute calcineurin inhibition with tacrolimus increases phosphorylated UT-A1. |
2012 |
Am. J. Physiol. Renal Physiol. |
pmid:22205230
|
Amberg GC et al. |
Regulation of A-type potassium channels in murine colonic myocytes by phosphatase activity. |
2001 |
Am. J. Physiol., Cell Physiol. |
pmid:11698261
|
Ahn HS et al. |
Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property. |
2007 |
Am. J. Physiol., Cell Physiol. |
pmid:17166943
|
Wang YX et al. |
FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:14592808
|
Sans MD and Williams JA |
Calcineurin is required for translational control of protein synthesis in rat pancreatic acini. |
2004 |
Am. J. Physiol., Cell Physiol. |
pmid:15044154
|
Bayguinov O et al. |
Muscarinic stimulation increases basal Ca(2+) and inhibits spontaneous Ca(2+) transients in murine colonic myocytes. |
2001 |
Am. J. Physiol., Cell Physiol. |
pmid:11171588
|
Angus LM et al. |
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction. |
2005 |
Am. J. Physiol., Cell Physiol. |
pmid:15930144
|
Zhang Y et al. |
K restriction inhibits protein phosphatase 2B (PP2B) and suppression of PP2B decreases ROMK channel activity in the CCD. |
2008 |
Am. J. Physiol., Cell Physiol. |
pmid:18184875
|
Yue G et al. |
The effect of rapamycin on single ENaC channel activity and phosphorylation in A6 cells. |
2000 |
Am. J. Physiol., Cell Physiol. |
pmid:10898719
|
Nam JH et al. |
Expression of TASK-2 and its upregulation by B cell receptor stimulation in WEHI-231 mouse immature B cells. |
2011 |
Am. J. Physiol., Cell Physiol. |
pmid:21307343
|
Nakagawa K et al. |
Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. |
2015 |
Am. J. Reprod. Immunol. |
pmid:25394810
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Saito S et al. |
Role of Paternal Antigen-Specific Treg Cells in Successful Implantation. |
2016 |
Am. J. Reprod. Immunol. |
pmid:26706630
|
Kofod L et al. |
Endometrial immune markers are potential predictors of normal fertility and pregnancy after in vitro fertilization. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28440588
|
Tabata C et al. |
Calcineurin/NFAT pathway: a novel regulator of parturition. |
2009 |
Am. J. Reprod. Immunol. |
pmid:19527231
|
Goldthorpe H et al. |
Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. |
2015 |
Am. J. Respir. Cell Mol. Biol. |
pmid:25879383
|
Fujiki M et al. |
Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice. |
1999 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10572064
|
Deuse T et al. |
Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:19880819
|
Rolfe FG et al. |
Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. |
1997 |
Am. J. Respir. Cell Mol. Biol. |
pmid:9271313
|
Yerkovich ST et al. |
Survival after bronchiolitis obliterans syndrome. |
2011 |
Am. J. Respir. Crit. Care Med. |
pmid:21325085
|
Bhorade S et al. |
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. |
2011 |
Am. J. Respir. Crit. Care Med. |
pmid:20833822
|
Koshika T et al. |
Pretreatment with FK506 improves survival rate and gas exchange in canine model of acute lung injury. |
2001 |
Am. J. Respir. Crit. Care Med. |
pmid:11208629
|
Saeki K et al. |
Endobronchial Lesions of Mycobacterium abscessus Infection in an Immunocompromised Patient. |
2017 |
Am. J. Respir. Crit. Care Med. |
pmid:28199133
|
Joshi MS et al. |
Calcineurin regulates myocardial function during acute endotoxemia. |
2006 |
Am. J. Respir. Crit. Care Med. |
pmid:16424445
|
Fauvel H et al. |
Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. |
2002 |
Am. J. Respir. Crit. Care Med. |
pmid:11850335
|
Spiekerkoetter E et al. |
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. |
2015 |
Am. J. Respir. Crit. Care Med. |
pmid:26177174
|
Raofi V et al. |
A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. |
1999 |
Am. J. Surg. |
pmid:10326847
|
Tanaka K et al. |
Living related liver transplantation in children. |
1994 |
Am. J. Surg. |
pmid:7517649
|
Li X et al. |
Increased iNOS-expressing macrophage in long-term surviving rat small-bowel grafts. |
2007 |
Am. J. Surg. |
pmid:17618815
|
Rabkin JM et al. |
Immunosuppression impact on long-term cardiovascular complications after liver transplantation. |
2002 |
Am. J. Surg. |
pmid:12034401
|
Jurim O et al. |
Living-donor liver transplantation at UCLA. |
1995 |
Am. J. Surg. |
pmid:7538267
|
Lee KK et al. |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. |
1993 |
Am. J. Surg. |
pmid:7678188
|
Finn L et al. |
Epstein-Barr virus infections in children after transplantation of the small intestine. |
1998 |
Am. J. Surg. Pathol. |
pmid:9500771
|
Randhawa PS et al. |
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. |
1993 |
Am. J. Surg. Pathol. |
pmid:7680544
|
Minervini MI et al. |
Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). |
2000 |
Am. J. Surg. Pathol. |
pmid:10757402
|
Randhawa PS et al. |
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. |
1996 |
Am. J. Surg. Pathol. |
pmid:8772784
|
Schnitzler M |
Diabetes mellitus after kidney transplantation in the United States. |
2003 |
Am. J. Transplant. |
pmid:14510709
|
Woodward RS et al. |
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. |
2003 |
Am. J. Transplant. |
pmid:12752315
|
Kim EJ et al. |
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. |
2014 |
Am. J. Transplant. |
pmid:24354871
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Tang Q |
Pharmacokinetics of therapeutic Tregs. |
2014 |
Am. J. Transplant. |
pmid:25358900
|
Wen X et al. |
Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27137884
|
Sikma MA et al. |
Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation. |
2015 |
Am. J. Transplant. |
pmid:26053114
|
English RF et al. |
Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipients. |
2002 |
Am. J. Transplant. |
pmid:12243498
|
Grimm M et al. |
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. |
2006 |
Am. J. Transplant. |
pmid:16686762
|
Sis B et al. |
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
2006 |
Am. J. Transplant. |
pmid:16686769
|
Bouamar R et al. |
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). |
2013 |
Am. J. Transplant. |
pmid:23480233
|
Busque S et al. |
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. |
2011 |
Am. J. Transplant. |
pmid:21943027
|
Flechner SM et al. |
Allotransplantation of cryopreserved parathyroid tissue for severe hypocalcemia in a renal transplant recipient. |
2010 |
Am. J. Transplant. |
pmid:20883540
|
BenÃtez CE et al. |
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20883560
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Rodriguez-Rodriguez AE et al. |
The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. |
2013 |
Am. J. Transplant. |
pmid:23651473
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Tan HP et al. |
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. |
2009 |
Am. J. Transplant. |
pmid:19120078
|
Ashman N et al. |
Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. |
2009 |
Am. J. Transplant. |
pmid:19120084
|
Vongwiwatana A et al. |
Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. |
2004 |
Am. J. Transplant. |
pmid:14678043
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Awadalla Y et al. |
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. |
2004 |
Am. J. Transplant. |
pmid:15367226
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Okabayashi T et al. |
Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination. |
2011 |
Am. J. Transplant. |
pmid:21883903
|
Hellemons ME et al. |
Former smoking is a risk factor for chronic kidney disease after lung transplantation. |
2011 |
Am. J. Transplant. |
pmid:21883906
|
Zheng H et al. |
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. |
2003 |
Am. J. Transplant. |
pmid:12694072
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
Ahsan N et al. |
Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. |
2002 |
Am. J. Transplant. |
pmid:12118902
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Heffron TG et al. |
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17511684
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Tedesco-Silva H et al. |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. |
2015 |
Am. J. Transplant. |
pmid:25988935
|
Vanhove T et al. |
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. |
2016 |
Am. J. Transplant. |
pmid:27013142
|
Teuteberg JJ et al. |
Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes. |
2010 |
Am. J. Transplant. |
pmid:19889126
|
De Simone P et al. |
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. |
2012 |
Am. J. Transplant. |
pmid:22882750
|
Turgut F and Akcay A |
Renal function estimation in cirrhosis. |
2009 |
Am. J. Transplant. |
pmid:19519814
|
Irish WD et al. |
Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database. |
2011 |
Am. J. Transplant. |
pmid:21564522
|
Tricot L et al. |
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. |
2009 |
Am. J. Transplant. |
pmid:19519819
|
Friman S et al. |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21564523
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|
Rogers J et al. |
Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. |
2003 |
Am. J. Transplant. |
pmid:14510702
|